Usefulness of cancer procoagulant (CP) in the detection of renal and bladder cancers

Barbara Darewicz; Jacek Kudelski; Lech Gałek; Małgorzata Gorzel; Sławomir Szajda; Tomasz Domel; Zdzisław Skrzydlewski

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

6/2003
vol. 7

Send email

Copy url:

abstract:

Usefulness of cancer procoagulant (CP) in the detection of renal and bladder cancers

Barbara Darewicz

,

Jacek Kudelski

,

Lech Gałek

,

Małgorzata Gorzel

,

Sławomir Szajda

,

Tomasz Domel

,

Zdzisław Skrzydlewski

Współcz Onkol (2003) vol. 7, 6 (401-403)

Online publish date: 2003/08/21

View full text Get citation

An early detection of neoplasm is of importance for its successful treatment. To do this biochemical cancer markers are often applied. A cancer procoagulant (CP) whose presence has been lately discovered in the serum of cancer patients but not in healthy persons seems to be the hopeful means to an end.
The aim of the investigation was to evaluate the usefulness of CP in renal and bladder cancer detection.
The evaluation of CP activity has been determined in 15 patients with renal cancer, 10 patients with bladder cancer and 10 healthy persons (the control group). The CP activity expressed by the coagulation time (in seconds) has been determined according to the Gordon and Benson’s coagulation method.
The parameter under investigation in serum of the patients reached a level of 101.0 s±23.4 s for kidney cancer, 79.4 s±17.4 s for bladder cancer and 294.6 s±24.4 s in healthy persons. The CP activity was higher in patients with bladder cancer as compared to those with renal cancer. The said difference was statistically significant (p<0.001).
That is why we suggest determining CP activity to be used in the oncological urology diagnostics.

keywords:

Usefulness of cancer procoagulant (CP) in the detection of renal and bladder cancers

Barbara Darewicz , Jacek Kudelski , Lech Gałek , Małgorzata Gorzel , Sławomir Szajda , Tomasz Domel , Zdzisław Skrzydlewski

cancer procoagulant, renal cancer, bladder cancer

Barbara Darewicz

,

Jacek Kudelski

,

Lech Gałek

,

Małgorzata Gorzel

,

Sławomir Szajda

,

Tomasz Domel

,

Zdzisław Skrzydlewski